Related Experiment Videos
Dose intensification and breast cancer: current results and future perspectives
1Department of Medical Oncology, Hôpital de la Salpétrière, Paris, France.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Trastuzumab duration effects within patient prognostic subgroups in the PHARE trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
Breast cancer research and treatment·2013
GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma.
Medical oncology (Northwood, London, England)·2011
Added value of molecular targeted agents in oncology.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Pancreatic cancer treatment and research: an international expert panel discussion.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Eight-year outcomes of testosterone suppression plus enzalutamide or a non-steroidal anti-androgen for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Pharmacokinetic Evaluation of Fibroblast Activation Protein-Targeted Radiopharmaceutical Uptake in Low-Stage Rectal Cancer Tumor Microenvironment.
Cancer biotherapy & radiopharmaceuticals·2026
A single-chip, dual-gain color-NIR camera for fluorescence-guided lung and breast cancer surgery.
Light, science & applications·2026